Cholera vaccines are designed for the protection from infections with the Vibrio cholerae bacterium.
| Name | Description | Marketing Authorisation Holder | Kind of Vaccine | License Number | License Date | Further Information |
|---|---|---|---|---|---|---|
|
Dukoral |
Cholera Impfstoff, inaktiviert, oral Verwendung ab einem Lebensalter von 2 Jahren / Use from 2 years of age onwards |
Valneva Sweden AB, 10521 Stockholm |
Mono | EU/1/03/263/001-003 | 03.05.2004 | |
Vaxchora |
Cholera-Impfstoff (rekombinant, lebend, zum Einnehmen) Verwendung ab einem Lebensalter von 2 Jahren / Use from 2 years of age onwards |
Bavarian Nordic A/S |
Mono | EU/1/20/1423 | 01.04.2020 |
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 530 in BAnz AT 16.06.2025 B4.
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.
Updated: 17.06.2025
Altersangaben für Impfstoffe.
Source: Paul-Ehrlich-Institut
Updated: 17.06.2025
